NEWS: Cohn and Wolfe launch new skin disorder product

Cohn and Wolfe Healthcare has been hired to launch a new product which decreases the side effects of skin disorder treatments.

Cohn and Wolfe Healthcare has been hired to launch a new product which

decreases the side effects of skin disorder treatments.



The agency will handle the pre-marketing and launch of the drug delivery

system Crys-talip, invented by the pharmaceutical company Bioglan.



The product cuts down on allergic reactions caused by the preservatives

which exist in most skin treatments by embedding the drug between layers

of crystals. This results in the slow release of the active compound and

removes the need to add preservatives.



The campaign will kick off with an educational programme targeted at GPs

and dermatologists to teach them about the system’s role in treating

skin disorders.



C&W will then handle the launch of specific drug brands based on the

technology.



Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.